THCV and Metabolic Health: A Targeted Approach to Appetite, Energy and Weight Regulation

Tetrahydrocannabivarin (THCV) is an emerging cannabinoid attracting interest for its potential role in appetite regulation, metabolic health, and reducing THC-related daytime impairment. Unlike THC, which is commonly associated with increased appetite and sedation, THCV exhibits unique pharmacological properties that may help support energy, function, and metabolic regulation in selected patients. This evidence-based webinar explores the pharmacology of THCV, its interaction with the endocannabinoid system, and the emerging research surrounding its potential applications in obesity, insulin resistance, metabolic syndrome, and THC-induced hyperphagia. Participants will examine how THCV differs from THC, review the current evidence, and discuss its potential role within a broader metabolic health strategy. The session will also highlight the importance of nutrition, lifestyle modification, and patient-centred care, providing practical guidance on patient selection, prescribing considerations, and monitoring strategies. Designed for healthcare professionals, this webinar offers a balanced and clinically relevant overview of THCV and its potential place in contemporary cannabinoid medicine.